BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 21763495)

  • 1. T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway.
    Kim YK; Mbonye U; Hokello J; Karn J
    J Mol Biol; 2011 Jul; 410(5):896-916. PubMed ID: 21763495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.
    Mbonye UR; Gokulrangan G; Datt M; Dobrowolski C; Cooper M; Chance MR; Karn J
    PLoS Pathog; 2013; 9(5):e1003338. PubMed ID: 23658523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome.
    Hokello J; Sharma AL; Tyagi M
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
    Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
    Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription.
    Liu P; Xiang Y; Fujinaga K; Bartholomeeusen K; Nilson KA; Price DH; Peterlin BM
    J Biol Chem; 2014 Apr; 289(14):9918-25. PubMed ID: 24515107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways.
    Mbonye U; Leskov K; Shukla M; Valadkhan S; Karn J
    PLoS Pathog; 2021 Sep; 17(9):e1009581. PubMed ID: 34529720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.
    Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression.
    Mbonye UR; Wang B; Gokulrangan G; Chance MR; Karn J
    Proteomics; 2015 Jun; 15(12):2078-86. PubMed ID: 25900325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.
    Bartholomeeusen K; Xiang Y; Fujinaga K; Peterlin BM
    J Biol Chem; 2012 Oct; 287(43):36609-16. PubMed ID: 22952229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction.
    Tyagi M; Pearson RJ; Karn J
    J Virol; 2010 Jul; 84(13):6425-37. PubMed ID: 20410271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent HIV-1 TAR Regulates 7SK-responsive P-TEFb Target Genes and Targets Cellular Immune Responses in the Absence of Tat.
    Eilebrecht S; Benecke BJ; Benecke AG
    Genomics Proteomics Bioinformatics; 2017 Oct; 15(5):313-323. PubMed ID: 29037489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling.
    Chen R; Liu M; Li H; Xue Y; Ramey WN; He N; Ai N; Luo H; Zhu Y; Zhou N; Zhou Q
    Genes Dev; 2008 May; 22(10):1356-68. PubMed ID: 18483222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells.
    Cho S; Schroeder S; Kaehlcke K; Kwon HS; Pedal A; Herker E; Schnoelzer M; Ott M
    EMBO J; 2009 May; 28(10):1407-17. PubMed ID: 19387490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.
    Schröder S; Cho S; Zeng L; Zhang Q; Kaehlcke K; Mak L; Lau J; Bisgrove D; Schnölzer M; Verdin E; Zhou MM; Ott M
    J Biol Chem; 2012 Jan; 287(2):1090-9. PubMed ID: 22084242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat.
    Muniz L; Egloff S; Ughy B; Jády BE; Kiss T
    PLoS Pathog; 2010 Oct; 6(10):e1001152. PubMed ID: 20976203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.
    Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R
    Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.
    Cho WK; Jang MK; Huang K; Pise-Masison CA; Brady JN
    J Virol; 2010 Dec; 84(24):12801-9. PubMed ID: 20926576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.
    D'Orso I; Jang GM; Pastuszak AW; Faust TB; Quezada E; Booth DS; Frankel AD
    Mol Cell Biol; 2012 Dec; 32(23):4780-93. PubMed ID: 23007159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
    Li Z; Guo J; Wu Y; Zhou Q
    Nucleic Acids Res; 2013 Jan; 41(1):277-87. PubMed ID: 23087374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.